The South African government says it could fill the potential gap in the number of doses it will need of the twice-yearly HIV-prevention jab to end Aids by 2043, by getting a group of local pharmaceutical companies to make generic shots from 2027 onwards. There is, however, a hitch. None of the companies that will be involved have a licence from lenacapavir’s inventor, Gilead Sciences, to make the jab.
Related Posts
News24 | ‘Not our war’: European leaders reject Trump pressure to join Iran fight
- CoreNews Africa
- March 19, 2026
- 0
German Chancellor Friedrich Merz said he agreed Iran must not be allowed to pose a threat to its neighbours, but expressed doubts about the rationale […]
Kwa-Thema Striders target 100% finish rate at Comrades Marathon
- CoreNews Africa
- June 12, 2026
- 0
Experienced runner Buti Nama hopes to secure a silver medal at this year’s Comrades after overcoming health challenges during the previous race.
News24 | Police partner with Mitchells Plain missing persons group in first-of-its-kind initiative
- CoreNews Africa
- July 9, 2026
- 0
The South African Police Service has, for the first time, formally partnered with a community missing persons organisation, working with Mitchells Plain-based Faith and Hope […]